Table 1.
Correlations between ER:PR-B interactions (signals/cell) and clinicopathological variables
| Variable | Spearman’s r | p | N |
|---|---|---|---|
| Age | 0.229 | 0.001 | 227 |
| Post-menopausal | 0.133 | 0.045 | 227 |
| T-stage | 0.056 | 0.405 | 227 |
| N-stage | –0.077 | 0.247 | 227 |
| Grade | –0.144 | 0.030 | 227 |
| Mitotic score | –0.198 | 0.003 | 227 |
| Multiple tumours | –0.039 | 0.555 | 227 |
| Mastectomy | –0.056 | 0.402 | 227 |
| Axillary clearance | −0.020 | 0.769 | 227 |
| Adjuvant chemotherapy | −0.058 | 0.382 | 226 |
| Adjuvant radiation | 0.019 | 0.778 | 224 |
| Adjuvant endocrine therapy | −0.044 | 0.511 | 226 |
| ER expression (allred score) | 0.567 | 0.001 | 227 |
| PR expression (allred score) | 0.199 | 0.003 | 227 |
| PR-B expression (PLA signals) | 0.352 | 0.001 | 227 |
The p value quoted is the result of a 2-tailed Spearman’s correlation. N is the number of patients with pairwise non-missing values